TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
21 mars 2024 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
20 mars 2024 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., March 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
29 févr. 2024 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Feb. 29, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23 févr. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Feb. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 janv. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Jan. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 déc. 2023 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Dec. 15, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Take Part in Connecting the Dots
05 déc. 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
16 nov. 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 nov. 2023 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Nov. 10, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Reports Third Quarter 2023 Financial Results
09 nov. 2023 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...